Dataset: Role of PRC2 complex components in prostate cancer cell lines
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
- Species:
- human
- Samples:
- 12
- Source:
- E-GEOD-39461
- PubMed:
- 23239736
- Updated:
- Dec.12, 2014
- Registered:
- Sep.19, 2014
Factors:
(via ArrayExpress)
| Sample | TREATMENT PROTOCOL | PASSAGES | VARIATION | CELL LINE | CHIP ANTIBODY |
|---|---|---|---|---|---|
| GSM969458 | under hormone depleted conditions | not specified | transfected with control siRNA | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969459 | under hormone depleted conditions | not specified | depleted of EZH2 | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969458 | under hormone depleted conditions | not specified | transfected with control siRNA | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969459 | under hormone depleted conditions | not specified | depleted of EZH2 | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969458 | under hormone depleted conditions | not specified | transfected with control siRNA | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969459 | under hormone depleted conditions | not specified | depleted of EZH2 | LNCaP-abl (abl) prostate cancer cells | not specified |
| GSM969464 | in the presence of DHT | not specified | transfected with control siRNA | LNCaP prostate cancer cells | not specified |
| GSM969465 | in the presence of DHT | not specified | depleted of EZH2 | LNCaP prostate cancer cells | not specified |
| GSM969464 | in the presence of DHT | not specified | transfected with control siRNA | LNCaP prostate cancer cells | not specified |
| GSM969465 | in the presence of DHT | not specified | depleted of EZH2 | LNCaP prostate cancer cells | not specified |
| GSM969464 | in the presence of DHT | not specified | transfected with control siRNA | LNCaP prostate cancer cells | not specified |
| GSM969465 | in the presence of DHT | not specified | depleted of EZH2 | LNCaP prostate cancer cells | not specified |